@article{6085c399e29740f7b75bd271ae5549f5,
title = "Is there a high-risk subgroup of stage i epithelial ovarian cancer that is most likely to benefit from 6 versus 3 cycles of adjuvant chemotherapy?",
keywords = "Carboplatin, Chemotherapy, Death from disease, Disease recurrence, Ovarian cancer, Paclitaxel",
author = "Bakkum-Gamez, {Jamie N.} and Richardson, {Debra L.} and Seamon, {Leigh G.} and Aletti, {Giovanni D.} and Powless, {Cecelia A.} and Keeney, {Gary L.} and O'Malley, {David M.} and Cliby, {William A.}",
year = "2010",
month = oct,
doi = "10.1111/IGC.0b013e3181efd843",
language = "English (US)",
volume = "20",
pages = "1125--1131",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Wolters Kluwer Health",
number = "7",
}